Novel Paradigms Governing β1-Adrenergic Receptor Trafficking in Primary Adult Rat Cardiac Myocytes

Mohammed M Nooh1, Salvatore Mancarella1, Suleiman W Bahouth2

  • 1Departments of Pharmacology (M.M.N., S.W.B.) and Physiology (S.M.), The University of Tennessee Health Sciences Center, Memphis, Tennessee; and Department of Biochemistry, Faculty of Pharmacy Cairo University, Cairo, Egypt (M.M.N.).

Insights

Cardiac beta1-adrenergic receptors (β1-AR) internalize into T-tubules upon stimulation and recycle back to the plasma membrane in adult rat ventricular myocytes via a novel sorting mechanism.

Area of Science:

  • Cardiovascular Physiology
  • Cellular Signaling
  • G protein-coupled receptors

Background:

  • The beta1-adrenergic receptor (β1-AR) is crucial for cardiac function and cardiovascular disease.
  • Catecholamine-induced β1-AR internalization and recycling are known in mammalian cells.
  • The behavior of β1-AR in terminally differentiated cardiac cells remained unclear.

Purpose of the Study:

  • To investigate the redistribution of β1-AR in terminally differentiated adult rat ventricular myocytes (ARVMs).
  • To elucidate the mechanisms governing β1-AR compartmentalization and recycling in response to adrenergic stimuli.

Main Methods:

  • Confocal microscopy was employed to visualize fluorescently labeled β1-AR in primary ARVMs.
  • ARVMs were treated with β-agonists (isoproterenol) and β-blockers (alprenolol).
  • T-tubule structures were identified using the membrane-impermeant dye Di-8 ANEPPS.

Main Results:

  • In unstimulated ARVMs, β1-AR localized to the cardiomyocyte sarcolemma.
  • Isoproterenol induced β1-AR internalization into T-tubules, forming distinct punctate structures.
  • Alprenolol promoted β1-AR translocation from T-tubules back to the plasma membrane.
  • Recycling was dependent on the type-1 PDZ binding motif and phosphorylation at serine 312.

Conclusions:

  • A novel sorting mechanism mediates β1-AR redistribution in ARVMs.
  • This mechanism involves translocation from internal structures to the plasma membrane.
  • Findings may explain unique cardiac β1-AR signaling in health and disease.

Related Concept Videos

Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
5.0K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.0K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.2K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.6K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.8K